Belfry
Medical Companion

Belfry Medical Companion

MDR-compliant mobile Health App for a medicinal cannabis inhaler

Usability Engineering

2023 - 2024

Belfry Medical GmbH

as a subsidiary of Sanity Group GmbH

Project profile

Belfry Medical specializes in therapies with controlled medical substances, utilizing a high-precision inhalation device with microgram-accurate dosing. To complement this hardware, the company pursued the goal of developing a digital solution that improves therapy tracking, strengthens patient engagement, and supports responsible therapy management. The objective was to develop a Mobile Health app that seamlessly connects with the inhaler while meeting the highest MDR-compliant requirements for safety and reliability.

Mission Statement

Patients receiving medical cannabis therapy in Germany are often at an advanced stage of severe conditions - such as cancer or motor impairments. For many, this treatment represents the last option in palliative care. Designing such a solution therefore required more than mere usability - it demanded empathy, trust-building, and particular sensitivity.


Our team developed the Belfry Medical Companion App - a user-centered, regulation-compliant digital tool that provides patients with transparency and control over their therapy. By displaying device status, capturing detailed therapy data, and offering a symptom diary, the app helps reduce the risk of dependency or misuse while improving therapy outcomes and cost-effectiveness. Features such as reimbursement support and smartphone-based inhaler control enable patients to manage their therapy responsibly and with confidence throughout the course of treatment.

BELFRY

MEDICAL COMPANION

MDR-compliant mobile Health App for a physical Medical Device

Product Design

Usability Engineering

2023 - 2024

Belfry Medical GmbH

as part of Sanity Group GmbH

Belfry Medical GmbH

as a subsidiary of Sanity Group GmbH

Belfry Medical specializes in controlled medical substance therapy through an advanced inhalation device, offering microgram-level precision dosing.


To improve treatment monitoring and help patients take control of their therapy, my team and I designed the user-centric Belfry Medical Companion App. This MDR-compliant mobile health solution offers full transparency throughout the treatment process, reduces the risk of addiction and misuse, and optimizes both outcomes and cost efficiency.


The Belfry Medical Companion supports responsible use of the cannabis inhaler by tracking device status, recording therapy data, and serving as a symptom diary. It logs usage history, provides timely reminders, and seamlessly links key inhaler functions to the user’s smartphone.

Mission Statement

Our team designed the Belfry Medical Companion App — a user-focused, compliant digital tool that provides patients with transparency and control over their therapy. By tracking device status, recording detailed therapy data, and offering a symptom diary, the app helps reduce the risk of addiction and misuse while optimizing treatment outcomes and cost efficiency. Features such as usage history, timely reminders, and smartphone-linked inhaler controls ensure patients can manage their therapy responsibly and with confidence throughout the entire treatment process.

Patients receiving medical cannabis therapy in Germany are often at an advanced stage of severe conditions - such as cancer or motor impairments. For many, this treatment represents the last option in palliative care. Designing such a solution therefore required more than mere usability - it demanded empathy, trust-building, and particular sensitivity.


Our team developed the Belfry Medical Companion App - a user-centered, regulation-compliant digital tool that provides patients with transparency and control over their therapy. By displaying device status, capturing detailed therapy data, and offering a symptom diary, the app helps reduce the risk of dependency or misuse while improving therapy outcomes and cost-effectiveness. Features such as reimbursement support and smartphone-based inhaler control enable patients to manage their therapy responsibly and with confidence throughout the course of treatment.

Project profile

Belfry Medical specializes in controlled medical substance therapy using an advanced inhalation device capable of microgram-level precision dosing. The company set out to complement this hardware with a digital solution that would enhance treatment monitoring, strengthen patient engagement, and support responsible therapy management. The goal was to create a mobile health application that not only integrates seamlessly with the inhaler but also meets strict MDR compliance standards for safety and reliability.

Belfry Medical specializes in therapies with controlled medical substances, utilizing a high-precision inhalation device with microgram-accurate dosing. To complement this hardware, the company pursued the goal of developing a digital solution that improves therapy tracking, strengthens patient engagement, and supports responsible therapy management. The objective was to develop a Mobile Health app that seamlessly connects with the inhaler while meeting the highest MDR-compliant requirements for safety and reliability.

Position and responsibilities

As Usability Engineering Lead and Art Director, I was responsible for a 5-member interdisciplinary team, ensuring the product was consistently grounded in patient-centered principles. I led a contextual research program that — despite initial reluctance and lack of trust on the part of patients — enabled direct dialogue with individuals undergoing cannabis therapy in Germany.


The insights uncovered fundamental needs, corrected initial assumptions, and formed the foundation for the UX/UI and design strategy I was responsible for. The complete usability file (per ISO 62366-1) was delivered within 2.5 months — on budget and within the regulatory timeline. The app is currently in the MDR submission process.

The Team

Team members obscured for data privacy reasons

Lead Usability Engineering

Research strategy and execution

Requirements analysis and conceptualization

Creative strategy and art direction

Sr. Researcher

Research strategy and execution

Insight analysis

Jr. Researcher

Research support

Insight analysis and documentation

Jr. Researcher

Forschungsunterstützung

Erkenntnisanalyse und Dokumentation

Sr. UX-Designer

Anforderungsanalyse und Konzeption

Low- & Hi-Fidelity Prototyping

Sr. UX-Designer

Requirements analysis and conceptualization

Low- & high-fidelity prototyping

Sr. UI-Designer

Interface Design

The Process

The development process followed a five-stage approach that systematically aligned stakeholder perspectives with real patient needs.


Step 1: Stakeholder Workshops

In three successive workshops with executive leadership and subject matter experts, the foundations were established: Which user groups use the application? Which therapy and business goals should it address? This resulted in a stakeholder-centered requirements analysis as a starting point for user-centered validation.

Step 2: User-Centered Validation

The developed assumptions were verified in the field: AI-assisted desk research helped to explore patient problem spaces in advance. Contextual interviews with real patients then made it possible to uncover the actual needs and gaps in the stakeholder perspective.


The results of the analysis phase were 4 strategically critical user needs:


  • Reimbursement support: Assistance with the application process for cost coverage. The process is opaque and, especially under stress, barely comprehensible for those affected.

  • Need-based inhalation guidance: Visual and auditory support should only assist when needed and be user-controlled.

  • Medication independence: A variety of medications from different manufacturers is unfortunately the norm of patient daily life. Enable tracking of different medication types, not only Belfry.

  • Documentation without overload: Reducing complex inputs to the essentials.


The research results led to a strategic reprioritization of the product roadmap — the originally planned feature set was restructured and comprehensively developed in favor of the four identified patient needs (Steps 3 & 4). Validation through summative usability testing (Step 5) using moderated interviews and the System Usability Scale confirmed the resulting benefits for users (SUS score 82.5).

Product Insights

Woman with a smartphone in her hand
Woman with a smartphone in her hand

Onboarding process

Three smartphones above each other
Three smartphones above each other

Belfry Medical Companion Dashboard

Smartphone standning behind medical cannabis inhaler
Smartphone standning behind medical cannabis inhaler

Treatment overview

Smartphone standning behind medical cannabis inhaler
Smartphone standning behind medical cannabis inhaler

Inhalation assistant

Smartphone in the hands of a user

Treatment Check-Up

Key Details & Numbers

Project duration

2,5 months

Creative Team led

5 designers / researchers

Contextual Interviews conducted

8x

Usability Tests conducted

10x

System Usability Scale Score

82.5 (Rating: "Excellent" per Bangor et al.; industry average: 68)

Methods

Stakeholder-Requirements Workshop

With company directors from varied business backgrounds, we clarified the clinical context and defined the core patient-centered problem, ensuring the team could think beyond purely commercial goals.

Stakeholder-Persona Workshop

We co-created realistic patient personas from different user groups to help a business-focused team design with genuine empathy.

Stakeholder-Product-Vision Workshop

Together, we envisioned the app as a trusted therapy companion, balancing business ambitions with empathy, clarity, and compliance.

Synthetic Interviews

AI-assisted interviews helped us validate early hypotheses and shape the discussion guides for contextual interviews, ensuring sensitive and relevant patient conversations.

Contextual Interviews

Revealed unmet needs, in particular the lack of support during the reimbursement process for patients with statutory health insurance, along with gaps in symptom tracking, progress visibility, and timely reminders. These patients are usually very emotionally affected due to the severity of their conditions, which required a sensitive and empathetic approach during interviews.

Usability testings

Usability sessions with real patients validated accessibility, tone, and workflows, adapting designs to their physical and emotional needs.

Regulatory Steps applied

Usability file documentation

(acc. to ISO 13485)

Analysis of hazardous situations

(acc. to ISO 14971)

Risk management documentation

(acc. to ISO 14971)

Establishing Usability Engineering process

(acc. to ISO 62366-1)

Research participants networks established

2x

Software Stack

Figma

Confluence

as Quality Management System

Adobe Creative Suit

After Effects, Photoshop, Illustrator

Berlin, 2026.

All images are presented for portfolio and illustrative purposes only. They are not licensed for commercial use, reproduction, or distribution.

Berlin, 2026.

All images are presented for portfolio and illustrative purposes only. They are not licensed for commercial use, reproduction, or distribution.